Publication management is a complex medical affairs process that involves stringent compliance requirements, numerous stakeholders, and multiple review and approval rounds. Whether you're waiting on a debarment check from another department or hounding reviewers to submit their feedback, keeping publication projects on track can be a real challenge.

Pharmaceutical organizations must constantly evolve in order to stay competitive in the market and compliant with regulations.

With all the hard work that goes into the complex and delicate process of medical innovation, the last thing pharmaceutical and biotech companies want is to see publications delayed by an incomplete or unnecessarily lengthy debarment check process.

Heavily regulated industries inherently have a lot of rules. The biotech and pharmaceutical industries are no exception. Adhering to complex regulations requires significant amounts of administrative work to ensure that the proper directives are being followed. Extensive regulations also present significant risks of hefty fines for noncompliance. Failed clinical trials also present a significant risk to pharmaceutical companies and can cost billions a year.